MSD, a research-intensive biopharmaceutical company based in New York, has launched IDEA Studios, a new initiative designed to fund and collaborate with entrepreneurs and early-stage companies focused on delivering transformative healthcare solutions in the Asia Pacific and Europe regions.
Spearheaded by the MSD Global Health Innovation Fund (MGHIF) and MSD’s regional teams, IDEA Studio Asia Pacific and IDEA Studio Europe will merge the parent company’s corporate venture arm with the healthcare expertise of its regional business units. MGHIF has committed to investing US$38 million in this initiative across both regions over the next three years.
MSD business teams in the Asia Pacific and Europe will work closely with MGHIF investors to identify and fund local entrepreneurs. IDEA Studio Asia Pacific, based in Singapore, aims to enhance access to vaccinations and cancer therapies, while the European unit, based in Berlin, focuses on innovating early disease diagnosis, improving medication adherence monitoring, and enhancing clinical trial recruitment strategies.
Joseph Romanelli, President of MSD Human Health International said, “We are constantly seeking to apply digital and data science technologies to improve patient outcomes and help accelerate our purpose of saving and improving lives. The launch of MSD IDEA Studios will offer entrepreneurs the opportunity to leverage our deep healthcare expertise to accelerate their impact and achieve meaningful innovation to improve patients’ lives.”
MGHIF is a growth investor that partners with innovative digital health and data science companies to facilitate and optimize biopharmaceutical operations and improve patient care. The investment strategy aims to connect companies with complementary technologies to develop integrated healthcare solutions.
MGHIF manages US$500 million and provides growth capital to emerging healthcare technology companies globally. With a vision that data will be the currency in healthcare, MGHIF invests broadly in digital health, targeting platform companies with proven technologies or business models where MSD’s expertise can accelerate revenue growth and enhance value creation.
Read More: Click Here
